This brand name is authorized in Brazil
The drug ADINOS GEN contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Desonide
UNII J280872D1O - DESONIDE
|
|
Desonide is a low-potency topical corticosteroid. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in the treatment of atopic dermatitis is unknown. |
|
2
Gentamicin
UNII 8X7386QRLV - GENTAMICIN SULFATE
|
|
Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D07BB02 | Desonide and antiseptics | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07B Corticosteroids, combinations with antiseptics → D07BB Corticosteroids, moderately potent, combinations with antiseptics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 500514801176311, 500514802172318, 500514803179316, 500514804175314 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
